TRxADE HEALTH Inc. (MEDS)
NASDAQ: MEDS
· Real-Time Price · USD
7.59
0.33 (4.55%)
At close: Sep 20, 2024, 10:00 PM
Company Description
TRxADE HEALTH, Inc. operates as a health services IT company in the United States.
The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement.
It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name.
The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021.
TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
TRxADE HEALTH Inc.
| Country | United States |
| IPO Date | Feb 6, 2014 |
| Industry | Medical - Pharmaceuticals |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Surendra K. Ajjarapu |
Contact Details
Address: 3840 Land O’ Lakes Boulevard Land O'Lakes, Florida United States | |
| Website | https://www.trxadehealth.com |
Stock Details
| Ticker Symbol | MEDS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001382574 |
| CUSIP Number | 89846A207 |
| ISIN Number | US89846A4058 |
| Employer ID | 00-0000000 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Surendra K. Ajjarapu | Chairman & Chief Executive Officer |
| Prashant Patel R.Ph. | Interim Chief Financial Officer, President, Chief Operating Officer & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 27, 2025 | 424B3 | Filing |
| Aug 25, 2025 | S-3 | Filing |
| Aug 20, 2025 | SCHEDULE 13G | Filing |
| Aug 19, 2025 | SCHEDULE 13G | Filing |
| Aug 15, 2025 | 8-K | Current Report |
| Aug 15, 2025 | 424B5 | Filing |
| Aug 12, 2025 | 10-Q | Quarterly Report |
| Aug 07, 2025 | D/A | [Amend] Filing |
| Aug 01, 2025 | S-3 | Filing |
| Aug 01, 2025 | D | Filing |